ProRx Pharma, a leading health and wellness 503B outsourcing facility, has announced an exclusive strategic partnership with Gatlan, a men's health brand founded by actor and director Josh Duhamel. The agreement, announced on May 13, 2025, establishes ProRx as the exclusive health and wellness provider for Gatlan's men's health venture, which offers testosterone replacement therapy, weight loss solutions, hair regrowth treatments, and other performance-focused health products.
"ProRx is proud to support Gatlan's bold vision for the men's health and wellness space," said Kurt Lunkwitz, chief operating officer of ProRx. "Working together, we'll be delivering products that are innovative, grounded in science, and manufactured with uncompromising quality."
The partnership strategically combines ProRx's expertise in pharmaceutical compounding and formulation development with Gatlan's customer-facing platform. This collaboration comes at a significant time, just ahead of Men's Health Month in June, highlighting both companies' commitment to advancing preventative care in the men's health sector.
Market Growth and Consumer Trends
The men's health market is experiencing substantial growth, with the Men's Health Supplements Market Report projecting the global market will reach $88.46 billion in 2025. This expansion reflects an increasing awareness among men about preventative healthcare and a growing willingness to take proactive approaches to personal wellness.
Josh Duhamel, founder of Gatlan, shared his personal motivation behind creating the brand: "As someone who has always pushed myself to be better, I was finding it more and more difficult to keep up with what I expected of myself as I got older. This stuff gave me my quality of life back and I want to help other men feel like themselves again."
Gatlan's mission focuses on helping men "feel strong, stay sharp, and live with purpose" through science-backed treatments and a holistic approach to wellness.
Clinical Expertise and Product Development
Dr. Robert Lufkin, chief medical advisor at Gatlan, New York Times bestselling author, and UCLA/USC Medical School professor, emphasized the scientific foundation of their approach: "Gatlan is reshaping the way men access health and wellness products by bridging the gap between science and everyday self-care. The partnership with ProRx allows us to expand our product offerings with even greater credibility and clinical integrity."
This announcement follows ProRx's recent expansion of its preventative health portfolio, which now includes 10 new offerings developed to support whole-body wellness. As an FDA-registered 503B facility, ProRx adheres to Current Good Manufacturing Practice (cGMP) standards, ensuring their products meet the same rigorous compliance requirements trusted by hospitals and clinical researchers nationwide.
Addressing Unmet Needs in Men's Health
The partnership addresses several key areas in men's health that have historically been underserved in the consumer market. Testosterone replacement therapy, which forms a core part of Gatlan's offerings, has shown clinical benefits for men with documented testosterone deficiency, including improved energy levels, increased muscle mass, enhanced mood, and better cognitive function.
Weight management solutions and hair regrowth treatments round out Gatlan's initial product lineup, targeting common concerns that impact men's confidence and quality of life. By providing these treatments through a platform backed by pharmaceutical expertise, the companies aim to elevate the standard of care available directly to consumers.
Regulatory Considerations and Quality Assurance
ProRx's status as a 503B outsourcing facility provides significant advantages for the partnership. These facilities operate under FDA oversight and are authorized to compound medications in anticipation of receiving patient-specific prescriptions. This designation ensures higher quality standards compared to traditional compounding pharmacies and allows for more consistent product availability.
The facility specializes in producing high-quality products during critical drug shortages, with particular emphasis on preventative health. This expertise will be leveraged to ensure Gatlan's offerings maintain pharmaceutical-grade quality while meeting the specific needs of their target demographic.
As men's health continues to evolve as a distinct medical specialty, partnerships like this one between ProRx and Gatlan may represent a new model for delivering specialized health products that combine clinical expertise with consumer accessibility.
